AcquisitionOther
QOL Medical, LLC acquired Evoke Pharma, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
QOL Medical, LLC -> Evoke Pharma, Inc. · $11.00 per share
Strategic value of its commercial product GIMOTI, first FDA-approved nasal spray for acute and recurrent diabetic gastroparesis.
Open source record (SEC) ↗